ETHAMBUTOL LAPL ethambutol hydrochloride 400 mg tablet bottle أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

ethambutol lapl ethambutol hydrochloride 400 mg tablet bottle

lupin australia pty limited - ethambutol hydrochloride, quantity: 400 mg - tablet, film coated - excipient ingredients: magnesium stearate; polyethylene glycol monomethyl ether; maize starch; povidone; hypromellose; titanium dioxide; ethylcellulose; purified talc; propylene glycol; colloidal anhydrous silica - ethambutol lapl is indicated for the treatment of pulmonary tuberculosis, as shown by a large number of studies by investigators throughout the world. it has also been used successfully in cases of primary tuberculosis and extrapulmonary forms of tuberculosis, including miliary tuberculosis, tuberculous meningitis, tuberculosis of bones and joints, genitourinary tuberculosis, tuberculosis of the skin and tuberculous eye diseases. it should not be used as the sole antituberculosis drug, but should be used in conjunction with at least one other antituberculosis drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety and appropriate in vitro susceptibility studies.,in patients who have not received previous antituberculosis therapy, i.e. initial treatment, the most frequently used regimens have included three of the following drugs ? ethambutol, isoniazid, rifampicin and streptomycin - for the first 2-4 months. for example:,? ethambutol plus isoniazid pl

ETHAMBUTOL LAPL ethambutol hydrochloride 400 mg tablet blister pack أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

ethambutol lapl ethambutol hydrochloride 400 mg tablet blister pack

lupin australia pty limited - ethambutol hydrochloride, quantity: 400 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; maize starch; purified talc; magnesium stearate; ethylcellulose; hypromellose; povidone; propylene glycol; polyethylene glycol monomethyl ether; titanium dioxide - ethambutol lapl is indicated for the treatment of pulmonary tuberculosis, as shown by a large number of studies by investigators throughout the world. it has also been used successfully in cases of primary tuberculosis and extrapulmonary forms of tuberculosis, including miliary tuberculosis, tuberculous meningitis, tuberculosis of bones and joints, genitourinary tuberculosis, tuberculosis of the skin and tuberculous eye diseases. it should not be used as the sole antituberculosis drug, but should be used in conjunction with at least one other antituberculosis drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety and appropriate in vitro susceptibility studies.,in patients who have not received previous antituberculosis therapy, i.e. initial treatment, the most frequently used regimens have included three of the following drugs ? ethambutol, isoniazid, rifampicin and streptomycin - for the first 2-4 months. for example:,? ethambutol plus isoniazid pl

ETHAMBUTOL GH ethambutol hydrochloride 400 mg tablet blister pack أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

ethambutol gh ethambutol hydrochloride 400 mg tablet blister pack

lupin australia pty limited - ethambutol hydrochloride, quantity: 400 mg - tablet, film coated - excipient ingredients: purified talc; magnesium stearate; hypromellose; titanium dioxide; colloidal anhydrous silica; propylene glycol; ethylcellulose; polyethylene glycol monomethyl ether; maize starch; povidone - ethambutol gh is indicated for the treatment of pulmonary tuberculosis, as shown by a large number of studies by investigators throughout the world. it has also been used successfully in cases of primary tuberculosis and extrapulmonary forms of tuberculosis, including miliary tuberculosis, tuberculous meningitis, tuberculosis of bones and joints, genitourinary tuberculosis, tuberculosis of the skin and tuberculous eye diseases. it should not be used as the sole antituberculosis drug, but should be used in conjunction with at least one other antituberculosis drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety and appropriate in vitro susceptibility studies.,in patients who have not received previous antituberculosis therapy, i.e. initial treatment, the most frequently used regimens have included three of the following drugs ? ethambutol, isoniazid, rifampicin and streptomycin - for the first 2-4 months. for example:,? ethambutol plus isoniazid plus rifampicin; or ? ethambutol plus isoniazid plus streptomycin,then continuing with a two drug regimen such as,? ethambutol plus isoniazid; or ? ethambutol plus rifampicin.,in patients who have received previous antituberculosis therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment cases ethambutol gh should be combined with at least one of the second-line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in vitro studies. antituberculosis drugs used with ethambutol have included cycloserine, ethionamide, pyrazinamide, viomycin and other drugs. isoniazid, aminosalicylic acid, and streptomycin have also been used in multiple drug regimens. alternating drug regimens have also been utilised.

Voractiv tablets المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

voractiv tablets

genus pharmaceuticals ltd - ethambutol hydrochloride; pyrazinamide; isoniazid; rifampicin - oral tablet - 275mg ; 400mg ; 75mg ; 150mg

Rifinah 300/150mg film-coated Tablets مالطا - الإنجليزية - Malta Medicines Authority

rifinah 300/150mg film-coated tablets

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - isoniazid, rifampicin - film-coated tablet - isoniazid 150 mg rifampicin 300 mg - antimycobacterials

Rifinah 150/100mg film-coated Tablets مالطا - الإنجليزية - Malta Medicines Authority

rifinah 150/100mg film-coated tablets

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - isoniazid, rifampicin - film-coated tablet - isoniazid 100 mg rifampicin 150 mg - antimycobacterials

ETHAMBUTOL;  ISONIAZID; PYRAZINAMIDE; RIFAMPICIN زيمبابوي - الإنجليزية - Medicines Control Authority

ethambutol; isoniazid; pyrazinamide; rifampicin

macleods pharmaceuticals ltd - ethambutol hydrochloride; isoniazid; pyrazinamide; rifampicin - tablet, coated; oral - 275; 75; 400; 150mg

RIFAMPICIN; ISONIAZID; ETHAMBUTOL زيمبابوي - الإنجليزية - Medicines Control Authority

rifampicin; isoniazid; ethambutol

macleods pharmaceuticals ltd - ethambutol hydrochloride; isoniazid; rifampicin - tablet, coated; oral - 275; 75; 150mg

RIFAMPICIN; ISONIAZID; PYRAZINAMIDE; ETHAMBUTOL HYDROCHLORIDE زيمبابوي - الإنجليزية - Medicines Control Authority

rifampicin; isoniazid; pyrazinamide; ethambutol hydrochloride

lupin limited - ethambutol hydrochloride; isoniazid; pyrazinamide; rifampicin - tablet, coated; oral - 275; 75; 400; 150mg

Rifampicin,Isoniazid, Pyrazinamide and Ethambutol Film Coated Tablet 150 mg/75 mg/400 mg/275 mg تانزانيا - الإنجليزية - Tanzania Medicinces & Medical Devices Authority

rifampicin,isoniazid, pyrazinamide and ethambutol film coated tablet 150 mg/75 mg/400 mg/275 mg

macleods pharmaceuticals limited, india - rifampicin, pyrazinamide, ethambutol , isoniazid - film coated tablet - 150 mg/75 mg/400 mg/275 mg